Simulations Plus Net Profit Margin 2010-2025 | SLP
Simulations Plus net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Simulations Plus Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2025-02-28 |
$0.08B |
$0.01B |
8.86% |
| 2024-11-30 |
$0.08B |
$0.01B |
10.67% |
| 2024-08-31 |
$0.07B |
$0.01B |
14.08% |
| 2024-05-31 |
$0.07B |
$0.01B |
14.71% |
| 2024-02-29 |
$0.07B |
$0.01B |
16.92% |
| 2023-11-30 |
$0.06B |
$0.01B |
17.46% |
| 2023-08-31 |
$0.06B |
$0.01B |
16.67% |
| 2023-05-31 |
$0.06B |
$0.01B |
17.86% |
| 2023-02-28 |
$0.06B |
$0.01B |
18.18% |
| 2022-11-30 |
$0.05B |
$0.01B |
18.52% |
| 2022-08-31 |
$0.05B |
$0.01B |
22.22% |
| 2022-05-31 |
$0.05B |
$0.01B |
21.15% |
| 2022-02-28 |
$0.05B |
$0.01B |
22.00% |
| 2021-11-30 |
$0.05B |
$0.01B |
20.83% |
| 2021-08-31 |
$0.05B |
$0.01B |
19.15% |
| 2021-05-31 |
$0.05B |
$0.01B |
23.40% |
| 2021-02-28 |
$0.05B |
$0.01B |
21.74% |
| 2020-11-30 |
$0.04B |
$0.01B |
20.93% |
| 2020-08-31 |
$0.04B |
$0.01B |
21.95% |
| 2020-05-31 |
$0.04B |
$0.01B |
23.08% |
| 2020-02-29 |
$0.04B |
$0.01B |
24.32% |
| 2019-11-30 |
$0.04B |
$0.01B |
25.71% |
| 2019-08-31 |
$0.03B |
$0.01B |
26.47% |
| 2019-05-31 |
$0.03B |
$0.01B |
24.24% |
| 2019-02-28 |
$0.03B |
$0.01B |
21.88% |
| 2018-11-30 |
$0.03B |
$0.01B |
25.81% |
| 2018-08-31 |
$0.03B |
$0.01B |
26.67% |
| 2018-05-31 |
$0.03B |
$0.01B |
27.59% |
| 2018-02-28 |
$0.03B |
$0.01B |
29.63% |
| 2017-11-30 |
$0.03B |
$0.01B |
23.08% |
| 2017-08-31 |
$0.02B |
$0.01B |
20.83% |
| 2017-05-31 |
$0.02B |
$0.01B |
22.73% |
| 2017-02-28 |
$0.02B |
$0.01B |
23.81% |
| 2016-11-30 |
$0.02B |
$0.01B |
25.00% |
| 2016-08-31 |
$0.02B |
$0.01B |
25.00% |
| 2016-05-31 |
$0.02B |
$0.00B |
20.00% |
| 2016-02-29 |
$0.02B |
$0.00B |
20.00% |
| 2015-11-30 |
$0.02B |
$0.00B |
20.00% |
| 2015-08-31 |
$0.02B |
$0.00B |
21.05% |
| 2015-05-31 |
$0.02B |
$0.00B |
23.53% |
| 2015-02-28 |
$0.02B |
$0.00B |
20.00% |
| 2014-11-30 |
$0.01B |
$0.00B |
23.08% |
| 2014-08-31 |
$0.01B |
$0.00B |
25.00% |
| 2014-05-31 |
$0.01B |
$0.00B |
25.00% |
| 2014-02-28 |
$0.01B |
$0.00B |
27.27% |
| 2013-11-30 |
$0.01B |
$0.00B |
27.27% |
| 2013-08-31 |
$0.01B |
$0.00B |
30.00% |
| 2013-05-31 |
$0.01B |
$0.00B |
30.00% |
| 2013-02-28 |
$0.01B |
$0.00B |
30.00% |
| 2012-11-30 |
$0.01B |
$0.00B |
30.00% |
| 2012-08-31 |
$0.01B |
$0.00B |
30.00% |
| 2012-05-31 |
$0.01B |
$0.00B |
30.00% |
| 2012-02-29 |
$0.01B |
$0.00B |
30.00% |
| 2011-11-30 |
$0.01B |
$0.00B |
30.00% |
| 2011-08-31 |
$0.01B |
$0.00B |
30.00% |
| 2011-05-31 |
$0.01B |
$0.00B |
30.00% |
| 2011-02-28 |
$0.01B |
$0.00B |
30.00% |
| 2010-11-30 |
$0.01B |
$0.00B |
30.00% |
| 2010-08-31 |
$0.01B |
$0.00B |
20.00% |
| 2010-05-31 |
$0.01B |
$0.00B |
20.00% |
| 2010-02-28 |
$0.01B |
$0.00B |
20.00% |
| 2009-11-30 |
$0.01B |
$0.00B |
11.11% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.640B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
